|Articles|January 18, 2002
CDER Drug Information, Updated 12/27/01
Author(s)BioPharm International Editors
New and Generic Drug Approvals [Includes Drug Label and Approval Letter] (Updated 12/27/2001)
Advertisement
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Eli Lilly Announces New $3.5 Billion Manufacturing Facility in Pennsylvania
2
Cellares Extends Cell Therapy Automation Beyond T Cell Therapies
3
FDA Clears Affinia’s AFTX-201 for Phase I/II BAG3 Cardiomyopathy Trial
4
High-Dose Nusinersen Slows Neurodegeneration in SMA Patients, Study Shows
5